Advertisement

Neurochemical Research

, Volume 16, Issue 3, pp 263–267 | Cite as

Glutamate decarboxylase activity in the substantia nigra and the hippocampus of rats microinjected with inhibitors of the enzyme

  • Ricardo Tapia
  • Patricia Salazar
Original Articles

Abstract

Three inhibitors of glutamate decarboxylase (GAD), acting through different mechanisms, as well as pyridoxal phosphate (PLP), were microinjected unilaterally by stereotaxic procedures into the substantia nigra reticulata or the CA1 area of the hippocampus of the rat. The inhibitors used were thiosemicarbazide (TSC), γ-glutamyl hydrazide and the PLP-glutamyl-hydrazone (PLPGH) formed by the combination of the latter with PLP. No behavioral alterations were observed after the administration of any of the drugs used, in any of the two brain regions studied. When measured in the absence of exogenous PLP, GAD activity in the substantia nigra injected with TSC was diminished by about 35%, and no changes were observed with the other drugs. In the CA1 hippocampal area both TSC and PLPGH inhibited GAD by more than 50%, and this inhibition was not reversed by PLP added in vitro. The results are discussed in terms of the possible explanation for the differences between the drugs used and for the lack of effects of GAD inhibition on the behavior of the animals.

Key Words

Glutamate decarboxylase substantia nigra hippocampus pyridoxal phosphate stereotaxic injections 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Tapia, R., Pérez de la Mora, M., and Massieu, G. H. 1969. Correlative changes of pyridoxal kinase, pyridoxal-5′-phosphate and glutamate decarboxylase in brain, during drug-induced convulsions. Ann. N.Y. Acad. Sci. 166:257–266.PubMedGoogle Scholar
  2. 2.
    Tapia, R. 1975. Biochemical pharmacology of GABA in CNS. Pages 1–58,in Iversen, L. L., Iversen, S. D., and Snyder S. H. (eds.) Handbook of Psychopharmacology, Vol. 4, Plenum Press, New York.Google Scholar
  3. 3.
    Meldrum, B. S. 1975. Epilepsy and gamma-aminobutyric acid-mediated inhibition. Intern. Rev. Neurobiol. 17:1–36.Google Scholar
  4. 4.
    Tower, D. B. 1976. GABA and seizures: clinical correlates in man. Pages 461–478,in Roberts, E., Chase, T.N., and Tower, D. B. (eds.) GABA in Neuvous System Function. Raven Press, New York.Google Scholar
  5. 5.
    Lloyd, K. G. 1987. Psychopharmacology of GABAergic drugs. Pages 183–195,in Meltzer, H. Y. (ed.) Psychopharmacology: The Third Generation of Progress. Raven Press, New York.Google Scholar
  6. 6.
    Pycock, C. J. 1980. Turning behavior in animals. Neuroscience 5:461–514.PubMedGoogle Scholar
  7. 7.
    Kilpatrick, I. C., and Starr, M. S. 1981. Involvement of dopamine in circling responses to muscimol depends on intranigral site of injection. Eur. J. Pharmacol. 69:407–419.PubMedGoogle Scholar
  8. 8.
    Tapia, R., and Flores-Hernández, J. 1990. Circling behavior induced by intranigral administration of ruthenium red and 4-aminopyridine in the rat. Neuroscience 39:657–663.PubMedGoogle Scholar
  9. 9.
    Wood, J. D., and Abrahams, D. E. 1971. The comparative effects of various hydrazides on γ-aminobutyric acid and its metabolism. J. Neurochem. 18:1017–1025.PubMedGoogle Scholar
  10. 10.
    Tapia, R., Pasantes, H., Ortega, B. G., and Massieu, G. H. 1966. Effects in vivo and in vitro ofl-glutamic acid-γ-hydrazide on metabolism of some free amino acids in brain and liver. Biochem. Pharmacol. 15:1831–1845.Google Scholar
  11. 11.
    Tapia, R., Pasantes, H., Pérez de la Mora, M., Ortega, B. G., and Massieu, G. H. 1967. Free amino acids and glutamate decarboxylase activity in brain of mice during drug-induced convulsions. Biochem. Pharmacol. 16:483–496.PubMedGoogle Scholar
  12. 12.
    Tapia, R., and Awapara, J. 1969. Effects of various substituted hydrazones and hydrazines of pyridoxal-5′-phosphate on brain glutamate decarboxylase. Biochem. Pharmacol. 18:145–152.PubMedGoogle Scholar
  13. 13.
    Díaz-Muñoz, M., and Tapia, R. 1988. Glutamate decarboxylase inhibition and vitamin B6 metabolism in brain of cirrhotic rats chronically treated with carbon tetrachloride. J. Neurosci. Res. 20:376–382.PubMedGoogle Scholar
  14. 14.
    Sah, J. 1954. Nicotinyl and isonicotinyl hydrazones of pyridoxal. J. Amer. Chem. Soc. 76:300.Google Scholar
  15. 15.
    König, J. F. R., and Klippel, R. A. 1963. The Rat Brain: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem. Williams and Wilkins, Baltimore.Google Scholar
  16. 16.
    Paxinos, G., and Watson, C. 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, Sidney.Google Scholar
  17. 17.
    Heffner, T. G., Hartman, J. A., and Seiden, L. S. 1980. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13:453–456.PubMedGoogle Scholar
  18. 18.
    Albers, R. W., and Brady, R. D. 1959. The distribution of glutamic acid decarboxylase in the nervous system of the Rhesus monkey. J. Biol. Chem. 234:926–928.PubMedGoogle Scholar
  19. 19.
    Lowry, O. Rosebrough, N., Farr, A., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265–275.PubMedGoogle Scholar
  20. 20.
    Killam, K. F. 1957. Convulsant hydrazides II: Comparison of electrical changes and enzyme inhibition induced by the administration of thiosemicarbazide. J. Pharmacol. Exp. Ther. 119:263–271.PubMedGoogle Scholar
  21. 21.
    Gale, K., and Iadarola, M. J. 1980. GABAergic denervation of rat substantia nigra: functional and pharmacological properties. Brain Res. 183:217–223.PubMedGoogle Scholar
  22. 22.
    Turski, L., Cavalheiro, E. A., Schwarz, M., Turski, W. A., de Moraes Mello, L. E. M., Bortolotto, Z. A., Klockgether, T., and Sontag, K.-H. 1986. Susceptibility to seizures produced by pilocarpine in rats after microinjection of isoniazid or γ-vinyl-GABA into the substantia nigra. Brain Res. 370:294–309.PubMedGoogle Scholar
  23. 23.
    Fragoso-Veloz, J., Massieu, L., Alvarado, R., and Tapia, R. 1990. Seizures and wet-dog shakes induced by 4-aminopyridine, and their potentiation by nifedipine. Eur. J. Pharmacol. 178:275–284.PubMedGoogle Scholar
  24. 24.
    Wiechert, P., and Herbst, A. 1966. Provocation of cerebral seizures by derangement of the natural balance between glutamic acid and γ-aminobutyric acid. J. Neurochem. 13:59–64.PubMedGoogle Scholar
  25. 25.
    Wiechert, P., and Göllnitz, G. 1968. Stoffwechseluntersuchungen des cerebralen Anfallsgeschehens: die Aktivität der Glutamat-Decarboxylase vor und während experimentell ausgelöster Krampfanfälle. J. Neurochem. 15:1265–1270.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • Ricardo Tapia
    • 1
  • Patricia Salazar
    • 1
  1. 1.Departamento de Neurociencias, Instituto de Fisiología CelularUniversidad Nacional Autónoma de MéxicoMéxicoMéxico

Personalised recommendations